002332 仙琚制药
已收盘 10-30 15:00:00
资讯
新帖
简况
【机构调研记录】东方证券调研仙琚制药、新宙邦等27只个股(附名单)
证券之星 · 10-29 08:17
【机构调研记录】东方证券调研仙琚制药、新宙邦等27只个股(附名单)
【机构调研记录】湘财基金调研仙琚制药、誉衡药业
证券之星 · 10-29 08:16
【机构调研记录】湘财基金调研仙琚制药、誉衡药业
【机构调研记录】嘉实基金调研托伦斯、仙琚制药等25只个股(附名单)
证券之星 · 10-29 08:15
【机构调研记录】嘉实基金调研托伦斯、仙琚制药等25只个股(附名单)
仙琚制药(002332)披露2026年三季度报告,10月26日股价上涨3.3%
证券之星 · 10-26
仙琚制药(002332)披露2026年三季度报告,10月26日股价上涨3.3%
图解仙琚制药三季报:第三季度单季净利润同比增长80.52%
证券之星 · 10-25
图解仙琚制药三季报:第三季度单季净利润同比增长80.52%
股市必读:仙琚制药(002332)股东户数4.7万户,较上期增加2.17%
证券之星 · 10-15
股市必读:仙琚制药(002332)股东户数4.7万户,较上期增加2.17%
仙琚制药:公司近期股东人数约为4万7千余户
证券之星 · 10-14
仙琚制药:公司近期股东人数约为4万7千余户
仙琚制药:截止近期,公司股东约4万6千户
证券之星 · 09-21
仙琚制药:截止近期,公司股东约4万6千户
仙琚制药:阿更葡糖钠注射液GMP符合性现场检查已结束
证券之星 · 09-17
仙琚制药:阿更葡糖钠注射液GMP符合性现场检查已结束
仙琚制药:截止近期,公司股东约4万6千户
证券之星 · 09-15
仙琚制药:截止近期,公司股东约4万6千户
研报掘金丨东方证券:维持仙琚制药“买入”评级,海外布局持续兑现,制剂管线储备丰富
格隆汇 · 09-14
研报掘金丨东方证券:维持仙琚制药“买入”评级,海外布局持续兑现,制剂管线储备丰富
股市必读:仙琚制药新发布《第九届董事会第七次(临时)会议决议公告》
证券之星 · 09-14
股市必读:仙琚制药新发布《第九届董事会第七次(临时)会议决议公告》
股市必读:仙琚制药新发布《第九届董事会第七次(临时)会议决议公告》
证券之星 · 09-11
股市必读:仙琚制药新发布《第九届董事会第七次(临时)会议决议公告》
仙琚制药(002332)披露关于放弃参股公司增资扩股优先认缴出资权的公告,9月10日股价下跌0.91%
证券之星 · 09-10
仙琚制药(002332)披露关于放弃参股公司增资扩股优先认缴出资权的公告,9月10日股价下跌0.91%
研报掘金丨浙商证券:维持仙琚制药“买入”评级,筑底回暖,蓄势向上
格隆汇 · 09-08
研报掘金丨浙商证券:维持仙琚制药“买入”评级,筑底回暖,蓄势向上
股市必读:仙琚制药(002332)股东户数4.5万户,较上期减少2.17%
证券之星 · 09-07
股市必读:仙琚制药(002332)股东户数4.5万户,较上期减少2.17%
仙琚制药(002332)9月3日股东户数4.5万户,较上期减少2.17%
证券之星 · 09-04
仙琚制药(002332)9月3日股东户数4.5万户,较上期减少2.17%
仙琚制药:截止近期,公司股东约4万5千户
证券之星 · 09-04
仙琚制药:截止近期,公司股东约4万5千户
仙琚制药(002332.SZ):黄体酮阴道片获得美国FDA注册申请受理
智通财经 · 09-01
仙琚制药(002332.SZ):黄体酮阴道片获得美国FDA注册申请受理
股市必读:仙琚制药中报 - 第二季度单季净利润同比下降8.29%
证券之星 · 08-31
股市必读:仙琚制药中报 - 第二季度单季净利润同比下降8.29%
公司概况
公司名称:
浙江仙琚制药股份有限公司
所属行业:
医药制造业
上市日期:
2010-01-12
主营业务:
浙江仙琚制药股份有限公司的主营业务是甾体激素类原料药及制剂的研发、生产与销售。公司的主要产品是皮质激素、性激素、孕激素、甾体衍生物。公司系国家企业技术中心及国家级制造业单项冠军企业。公司在中国医药工业信息中心主办的第43届全国医药工业信息年会中荣获“2025年度中国医药工业主营业务收入百强”及“中国医药工业最具投资价值医药企业”;成功入选2026年浙江省未来工厂培育试点企业。
发行价格:
8.20
{"stockData":{"symbol":"002332","market":"SZ","secType":"STK","nameCN":"仙琚制药","latestPrice":8.89,"timestamp":1793343804000,"preClose":8.86,"halted":0,"volume":13944398,"delay":0,"changeRate":0.0034,"floatShares":986000000,"shares":989000000,"eps":0.4703,"marketStatus":"已收盘","change":0.03,"latestTime":"10-30 15:00:00","open":8.81,"high":8.98,"low":8.8,"amount":124000000,"amplitude":0.0203,"askPrice":8.89,"askSize":870,"bidPrice":8.88,"bidSize":1306,"shortable":0,"etf":0,"ttmEps":0.4703,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":8.86,"symbolType":"stock","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":9.75,"lowLimit":7.97,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":989204866,"isCdr":false,"pbRate":1.49,"roa":"--","peRate":18.902828,"roe":"6.96%","epsLYR":0.45,"committee":-0.040782,"marketValue":8794000000,"turnoverRate":0.0141,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-11-02。","floatMarketCap":8763000000},"requestUrl":"/m/hq/s/002332/wiki","defaultTab":"wiki","newsList":[{"id":"2679445043","title":"【机构调研记录】东方证券调研仙琚制药、新宙邦等27只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2679445043","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679445043?lang=zh_cn&edition=full","pubTime":"2026-10-29 08:17","pubTimestamp":1793233070,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月28日披露的机构调研信息,东方证券近期对27家上市公司进行了调研。制剂销售基本持平,原料药增长10%。三季度资产负债率上升因猪价低于成本线导致经营承压、新增流贷及环控改造借款。未来将动态调整现金储备,保障现金流安全。2026年前三季度经营性净现金流84.1亿元,资产负债率降至38.17%,已压降有息负债37亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900012551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0076","BK0003","BK0028","03958","SG9999014674.SGD","BK0239","BK0155","300037","002332","BK1147","BK0188","BK0132","600958","BK0276","BK0183","IE0005HP3H50.USD","BK1564","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679445700","title":"【机构调研记录】湘财基金调研仙琚制药、誉衡药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2679445700","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679445700?lang=zh_cn&edition=full","pubTime":"2026-10-29 08:16","pubTimestamp":1793233011,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月28日披露的机构调研信息,湘财基金近期对2家上市公司进行了调研,相关名单如下:1)仙琚制药 调研纪要:2026年前三季度收入29.28亿元,同比增长3.6%;净利润4.22亿元,同比增长3.82%。制剂销售基本持平,原料药增长10%。湘财基金成立于2018年,截至目前,资产管理规模57.25亿元;资产管理规模30.45亿元;管理公募基金数44只;旗下公募基金经理8人。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900012478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002437","BK0077","BK0028","BK0060","SG9999014674.SGD","BK0188","002332","BK0095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679719445","title":"【机构调研记录】嘉实基金调研托伦斯、仙琚制药等25只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2679719445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679719445?lang=zh_cn&edition=full","pubTime":"2026-10-29 08:15","pubTimestamp":1793232939,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及10月28日披露的机构调研信息,嘉实基金近期对25家上市公司进行了调研,相关名单如下:1)托伦斯 调研纪要:公司目前在手订单超过6亿元,较6月30日增长93%,订单储备充足。制剂销售基本持平,原料药增长10%。毛利率达24%,创年内新高,主要受益于磷酸铁业务贡献。蚌埠基地已于2026年三季度开始贡献业绩。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900012424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301583","SG9999014674.SGD","BK0239","002332","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678985161","title":"仙琚制药(002332)披露2026年三季度报告,10月26日股价上涨3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678985161","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678985161?lang=zh_cn&edition=full","pubTime":"2026-10-26 18:07","pubTimestamp":1793009246,"startTime":"0","endTime":"0","summary":"截至2026年10月26日收盘,仙琚制药报收于9.07元,较前一交易日上涨3.3%,最新总市值为89.72亿元。该股当日开盘8.81元,最高9.1元,最低8.78元,成交额达3.54亿元,换手率为3.99%。仙琚制药于近日披露《2026年三季度报告》。公告显示,公司2026年第三季度营业收入969,738,724.47元,同比增长1.40%;归属于上市公司股东的净利润177,661,860.30元,同比增长80.52%。年初至报告期末营业收入2,928,372,588.69元,同比增长3.64%;归属于上市公司股东的净利润422,214,882.68元,同比增长3.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600024958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","SG9999014674.SGD","002332","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678187970","title":"图解仙琚制药三季报:第三季度单季净利润同比增长80.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678187970","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678187970?lang=zh_cn&edition=full","pubTime":"2026-10-25 16:49","pubTimestamp":1792918193,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药2026年三季报显示,前三季度公司主营收入29.28亿元,同比上升3.64%;归母净利润4.22亿元,同比上升3.82%;扣非净利润3.61亿元,同比下降0.59%;其中2026年第三季度,公司单季度主营收入9.7亿元,同比上升1.4%;单季度归母净利润1.78亿元,同比上升80.52%;单季度扣非净利润1.19亿元,同比上升23.53%;负债率16.09%,投资收益-1454.59万元,财务费用733.46万元,毛利率61.75%。财报数据概要请见下图:本文数据来源于仙琚制药2026年三季报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102500004450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675266329","title":"股市必读:仙琚制药(002332)股东户数4.7万户,较上期增加2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675266329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675266329?lang=zh_cn&edition=full","pubTime":"2026-10-15 01:49","pubTimestamp":1792000150,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘,仙琚制药报收于8.74元,上涨0.58%,换手率1.35%,成交量13.3万手,成交额1.16亿元。股本股东变化股东户数变动截至2026年10月13日,仙琚制药股东户数为4.7万户,较9月18日增加1000户,增幅2.17%;户均持股数量由2.15万股减少至2.1万股,户均持股市值为18.29万元。公司近期股东人数约为4万7千余户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500001640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0239","BK0028","002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675392060","title":"仙琚制药:公司近期股东人数约为4万7千余户","url":"https://stock-news.laohu8.com/highlight/detail?id=2675392060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675392060?lang=zh_cn&edition=full","pubTime":"2026-10-14 11:36","pubTimestamp":1791948976,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药(002332)10月14日在投资者关系平台上答复投资者关心的问题。投资者提问:请问一下截止9月10日股东人数?谢谢!仙琚制药回复:您好!感谢您对公司的关注。公司近期股东人数约为4万7千余户。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400016424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0239","002332","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669153373","title":"仙琚制药:截止近期,公司股东约4万6千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2669153373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669153373?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:07","pubTimestamp":1789974441,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药(002332)09月21日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年9月20日A股股东人数是多少?谢谢仙琚制药回复:您好,感谢您的关注!截止近期,公司股东约4万6千户。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100013470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332","SG9999014674.SGD","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668953377","title":"仙琚制药:阿更葡糖钠注射液GMP符合性现场检查已结束","url":"https://stock-news.laohu8.com/highlight/detail?id=2668953377","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668953377?lang=zh_cn&edition=full","pubTime":"2026-09-17 11:33","pubTimestamp":1789615990,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药09月17日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,想咨询下阿更葡糖钠注射液的进展:1、目前该品种的GMP符合性现场检查是否已经开展?据了解,阿更葡糖钠注射液的GMP符合性现场检查已结束,目前处于检查后的补充资料提交阶段。目前正在逐步推进该产品的各省挂网工作。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091700014448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","SG9999014674.SGD","002332","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667613973","title":"仙琚制药:截止近期,公司股东约4万6千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2667613973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667613973?lang=zh_cn&edition=full","pubTime":"2026-09-15 11:37","pubTimestamp":1789443465,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药(002332)09月15日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年9月10日A股股东人数是多少?谢谢仙琚制药回复:您好,感谢您的关注!截止近期,公司股东约4万6千户。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091500015764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","002332","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656193","title":"研报掘金丨东方证券:维持仙琚制药“买入”评级,海外布局持续兑现,制剂管线储备丰富","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656193","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667656193?lang=zh_cn&edition=full","pubTime":"2026-09-14 16:01","pubTimestamp":1789372876,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["002332","600958","BK0028","BK0276","BK0012","SG9999014674.SGD","BK0183","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667806016","title":"股市必读:仙琚制药新发布《第九届董事会第七次(临时)会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667806016","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667806016?lang=zh_cn&edition=full","pubTime":"2026-09-14 01:49","pubTimestamp":1789321748,"startTime":"0","endTime":"0","summary":"公司公告汇总第九届董事会第七次(临时)会议决议公告浙江仙琚制药股份有限公司于2026年9月10日召开第九届董事会第七次(临时)会议,审议通过《关于放弃参股公司增资扩股优先认缴出资权的议案》和《关于参股公司拟退出小额贷款行业及拟减资的议案》。会议应参与董事9名,实际参与9名,表决结果均为9票同意,0票弃权,0票反对。本次事项经仙琚制药第九届董事会第七次(临时)会议审议通过,无需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0028","BK0239","002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666908105","title":"股市必读:仙琚制药新发布《第九届董事会第七次(临时)会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666908105","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666908105?lang=zh_cn&edition=full","pubTime":"2026-09-11 01:38","pubTimestamp":1789061891,"startTime":"0","endTime":"0","summary":"公司公告汇总第九届董事会第七次(临时)会议决议公告浙江仙琚制药股份有限公司于2026年9月10日召开第九届董事会第七次(临时)会议,审议通过《关于放弃参股公司增资扩股优先认缴出资权的议案》和《关于参股公司拟退出小额贷款行业及拟减资的议案》。会议应参与董事9名,实际参与9名,表决结果均为9票同意,0票弃权,0票反对。本次事项经仙琚制药第九届董事会第七次(临时)会议审议通过,无需提交股东大会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002340.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","SG9999014674.SGD","002332","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591409","title":"仙琚制药(002332)披露关于放弃参股公司增资扩股优先认缴出资权的公告,9月10日股价下跌0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666591409?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:25","pubTimestamp":1789050317,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,仙琚制药报收于8.73元,较前一交易日下跌0.91%,最新总市值为86.36亿元。该股当日开盘8.83元,最高8.85元,最低8.69元,成交额达7581.79万元,换手率为0.88%。公告显示,公司持有参股公司浙江萃泽医药科技有限公司32.1957%股权。仙琚制药放弃本次增资扩股优先认缴出资权,持股比例将由32.1957%下降至31.4512%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332","BK0028","BK0239","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665345340","title":"研报掘金丨浙商证券:维持仙琚制药“买入”评级,筑底回暖,蓄势向上","url":"https://stock-news.laohu8.com/highlight/detail?id=2665345340","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665345340?lang=zh_cn&edition=full","pubTime":"2026-09-08 14:44","pubTimestamp":1788849852,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["601878","BK0028","002332","BK0276","SG9999014674.SGD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665395367","title":"股市必读:仙琚制药(002332)股东户数4.5万户,较上期减少2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665395367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665395367?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:44","pubTimestamp":1788716652,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,仙琚制药报收于8.68元,下跌0.34%,换手率1.4%,成交量13.83万手,成交额1.2亿元。股本股东变化:截至2026年9月3日,仙琚制药股东户数为4.5万户,较8月24日减少1000户,减幅2.17%。股本股东变化股东户数变动截至2026年9月3日公司股东户数为4.5万户,较8月24日减少1000.0户,减幅为2.17%;户均持股数量由上期的2.15万股增加至2.2万股,户均持股市值为19.15万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002332","SG9999014674.SGD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664333312","title":"仙琚制药(002332)9月3日股东户数4.5万户,较上期减少2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664333312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664333312?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:33","pubTimestamp":1788514423,"startTime":"0","endTime":"0","summary":"证券之星消息,近日仙琚制药披露,截至2026年9月3日公司股东户数为4.5万户,较8月24日减少1000.0户,减幅为2.17%。在化学制药行业个股中,仙琚制药股东户数高于行业平均水平,截至9月3日,化学制药行业平均股东户数为3.65万户。从股价来看,2026年8月24日至2026年9月3日,仙琚制药区间涨幅为3.2%,在此期间股东户数减少1000.0户,减幅为2.17%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400030899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999014674.SGD","BK0239","BK0028","002332"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664863313","title":"仙琚制药:截止近期,公司股东约4万5千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863313","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664863313?lang=zh_cn&edition=full","pubTime":"2026-09-04 11:37","pubTimestamp":1788493036,"startTime":"0","endTime":"0","summary":"证券之星消息,仙琚制药(002332)09月03日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年8月31日A股股东人数是多少?谢谢仙琚制药回复:您好,感谢您的关注!截止近期,公司股东约4万5千户。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400016728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002332","BK0028","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385320","title":"仙琚制药(002332.SZ):黄体酮阴道片获得美国FDA注册申请受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385320","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664385320?lang=zh_cn&edition=full","pubTime":"2026-09-01 19:00","pubTimestamp":1788260459,"startTime":"0","endTime":"0","summary":"智通财经APP讯,仙琚制药(002332.SZ)发布公告,公司向美国食品药品监督管理局(简称“FDA”)递交了黄体酮阴道片的ANDA注册申请,公司于近日收到美国FDA注册申请受理的通知。黄体酮阴道片适应症为辅助生殖ART黄体支持,通过补充黄体功能,支持胚胎着床与早期妊娠。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002332","LABU","SG9999014674.SGD","BK0028","BK0239","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663028661","title":"股市必读:仙琚制药中报 - 第二季度单季净利润同比下降8.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663028661","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663028661?lang=zh_cn&edition=full","pubTime":"2026-08-31 07:54","pubTimestamp":1788134052,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年中报显示归母净利润2.45亿元,同比下降20.67%;第二季度扣非净利润同比上升23.82%。其中第二季度单季度主营收入10.4亿元,同比上升20.82%;单季度归母净利润1.51亿元,同比下降8.29%;单季度扣非净利润1.52亿元,同比上升23.82%;负债率15.23%,投资收益-910.33万元,财务费用533.46万元,毛利率62.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100001989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002332"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793445997249,"stockEarnings":[{"period":"1week","weight":0.0125},{"period":"1month","weight":0.0289},{"period":"3month","weight":0.0492},{"period":"6month","weight":0.0502},{"period":"1year","weight":-0.0148},{"period":"ytd","weight":0.0223}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江仙琚制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"47000人(较上一季度增加0.54%)","perCapita":"20972股","listingDate":"2010-01-12","address":"浙江省台州市仙居县仙药路1号","registeredCapital":"98920万元","survey":" 浙江仙琚制药股份有限公司的主营业务是甾体激素类原料药及制剂的研发、生产与销售。公司的主要产品是皮质激素、性激素、孕激素、甾体衍生物。公司系国家企业技术中心及国家级制造业单项冠军企业。公司在中国医药工业信息中心主办的第43届全国医药工业信息年会中荣获“2025年度中国医药工业主营业务收入百强”及“中国医药工业最具投资价值医药企业”;成功入选2026年浙江省未来工厂培育试点企业。","listedPrice":8.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仙琚制药(002332)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仙琚制药(002332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仙琚制药,002332,仙琚制药股票,仙琚制药股票老虎,仙琚制药股票老虎国际,仙琚制药行情,仙琚制药股票行情,仙琚制药股价,仙琚制药股市,仙琚制药股票价格,仙琚制药股票交易,仙琚制药股票购买,仙琚制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仙琚制药(002332)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仙琚制药(002332)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}